Abstract
Medicinal combinations of Isaria japonica (Paecilomyces tenuipes, Paecilomyces japonica, and Isaria tenuipes) and the silkworm Bombyx mori are commercially available in Japan, China, and Korea. Isaria japonica exhibits host specificity for lepidopteran insects and can be cultured in the insect’s body. Recently, a hot-water extract of an I. japonica product (“IJE”) was shown to prevent brain function decline in aging mice. Therefore, evaluating the safety profile of IJE is worthwhile. Acute toxicity experiments were performed on adult female ICR mice (8-10 weeks old; 25-35 g). Sub-chronic toxicity experiments on adult female Wistar rats (8-10 weeks old; 130-150 g) assessed general behavior, mortality, body weight, food + water consumption, hematology, blood chemistry, relative organ weights and histopathology. IJE caused neither significant visible signs of toxicity nor mortality in ICR mice. In the sub-chronic toxicity analysis, administration of IJE to Wistar rats at doses of 25 and 500 mg/kg for 28 consecutive days did not cause mortality. No significant differences were found in food or water consumption, hematological parameters, or relative organ weights between the treated and control groups. IJE appears to be safe when administered orally.
Keywords: Acute toxicity, Animals, Biochemical parameters, Hot-water extract, Isaria japonica, subchronic toxicity.
Current Traditional Medicine
Title:Acute and Sub-chronic Toxicity Analyses of Hot-Water Extract of Isaria japonica from Silkworm (Bombyx mori) Pupae
Volume: 1 Issue: 3
Author(s): Piyamas Sillapakong, Masanobu Goryo, Jun Sasaki, Shinichi Oda, Takashi Hiraga, Shorta Uchiyama, Eiji Nishimura, Tetsuro Shinada, Chigumi Ohtsuka, Yasuo Terayama and Koichi Suzuki
Affiliation:
Keywords: Acute toxicity, Animals, Biochemical parameters, Hot-water extract, Isaria japonica, subchronic toxicity.
Abstract: Medicinal combinations of Isaria japonica (Paecilomyces tenuipes, Paecilomyces japonica, and Isaria tenuipes) and the silkworm Bombyx mori are commercially available in Japan, China, and Korea. Isaria japonica exhibits host specificity for lepidopteran insects and can be cultured in the insect’s body. Recently, a hot-water extract of an I. japonica product (“IJE”) was shown to prevent brain function decline in aging mice. Therefore, evaluating the safety profile of IJE is worthwhile. Acute toxicity experiments were performed on adult female ICR mice (8-10 weeks old; 25-35 g). Sub-chronic toxicity experiments on adult female Wistar rats (8-10 weeks old; 130-150 g) assessed general behavior, mortality, body weight, food + water consumption, hematology, blood chemistry, relative organ weights and histopathology. IJE caused neither significant visible signs of toxicity nor mortality in ICR mice. In the sub-chronic toxicity analysis, administration of IJE to Wistar rats at doses of 25 and 500 mg/kg for 28 consecutive days did not cause mortality. No significant differences were found in food or water consumption, hematological parameters, or relative organ weights between the treated and control groups. IJE appears to be safe when administered orally.
Export Options
About this article
Cite this article as:
Sillapakong Piyamas, Goryo Masanobu, Sasaki Jun, Oda Shinichi, Hiraga Takashi, Uchiyama Shorta, Nishimura Eiji, Shinada Tetsuro, Ohtsuka Chigumi, Terayama Yasuo and Suzuki Koichi, Acute and Sub-chronic Toxicity Analyses of Hot-Water Extract of Isaria japonica from Silkworm (Bombyx mori) Pupae, Current Traditional Medicine 2015; 1 (3) . https://dx.doi.org/10.2174/221508380103151231145946
DOI https://dx.doi.org/10.2174/221508380103151231145946 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Gene Strategies to Down-Regulate Gene Expression in Mammalian Cells
Current Pharmaceutical Design Traditional Chinese Medicines (TCMs) for Molecular Targeted Therapies of Tumours
Current Drug Discovery Technologies Pharmaceutical Applications of the Benzylisoquinoline Alkaloids from Argemone mexicana L.
Current Topics in Medicinal Chemistry Eph/Ephrin Membrane Proteins: A Mammalian Expression Vector pTIg- BOS-Fc Allowing Rapid Protein Purification
Protein & Peptide Letters Small Molecule Tyrosine Kinase Inhibitors: Potential Role in Pediatric Malignant Solid Tumors
Current Cancer Drug Targets Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions
Recent Patents on Anti-Cancer Drug Discovery Proteasome Inhibitors and Modulators of Angiogenesis in Multiple Myeloma
Current Medicinal Chemistry A Better Platinum-Based Anticancer Drug Yet to Come?
Anti-Cancer Agents in Medicinal Chemistry Novel and Emerging Drugs for Acute Lymphoblastic Leukemia
Current Cancer Drug Targets The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology The Rational Design of Anticancer Platinum Complexes: The Importance of the Structure-Activity Relationship
Current Medicinal Chemistry OPLS-DA as a Suitable Method for Selecting a Set of Gene Transcripts Discriminating RAS- and PTPN11-Mutated Cells in Acute Lymphoblastic Leukaemia
Combinatorial Chemistry & High Throughput Screening Medicinal Plants from Peru: A Review of Plants as Potential Agents Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Exploiting Innate γδ T Lymphocytes for Tumor Immunotherapy
Recent Patents on Biomarkers Trp/Met/Phe Hot Spots in Protein-Protein Interactions: Potential Targets in Drug Design
Current Topics in Medicinal Chemistry Recent Advances in Small Molecule Prodrugs for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Current Cancer Drug Targets Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Synthesis and Biological Applications of Triazole Derivatives – A Review
Mini-Reviews in Organic Chemistry The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis
Current Cancer Drug Targets